Congenital anomalies associated with the use of cardiovascular drugs during pregnancy: a large-scale data analysis from the FAERS database
Enhanced monitoring is recommended for fetal malformations in women exposed to these drugs before or during pregnancy. While our findings suggest associations, they do not establish causality, highlighting the need for further research to ensure medication safety during pregnancy.
Authors
- Chufeng Din
- Yuting Wang (ORCID: https://orcid.org/0000-0002-1443-2643)
- Lin Ma (ORCID: https://orcid.org/0009-0005-2568-2735)
- Jingping Zheng (ORCID: https://orcid.org/0000-0002-9770-4308)
- Zhenpo Zhang (ORCID: https://orcid.org/0009-0006-8175-4972)
- Qimin Wu
- Yankun Liang
- Ling Su (ORCID: https://orcid.org/0000-0002-0594-9181)
- Jian Tan (ORCID: https://orcid.org/0000-0002-4160-4535)
Institutions
- Guangzhou University of Chinese Medicine (CN)
- Jinan University (CN)
- Beijing Xuanwu Traditional Chinese Medicine Hospital (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-12-13
- DOI
- https://doi.org/10.1080/14740338.2024.2442519
- Citations
- 3
- Primary Topic
- Cardiovascular Issues in Pregnancy
- Type
- article
- Field-Weighted Citation Impact
- 1.21